Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020

SELL
$8.11 - $15.23 $262,277 - $492,538
-32,340 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$13.96 - $18.26 $451,466 - $590,528
32,340 New
32,340 $553,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Lingohr & Partner Asset Management Gmb H Portfolio

Follow Lingohr & Partner Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.